These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6478466)

  • 41. Efficacy of verapamil in exercise-induced ventricular tachycardia.
    Woelfel A; Foster JR; McAllister RG; Simpson RJ; Gettes LS
    Am J Cardiol; 1985 Aug; 56(4):292-7. PubMed ID: 4025168
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sustained ventricular tachycardia responsive to verapamil in patients with hypertrophic cardiomyopathy. Clinical and electrophysiological assessment of drug efficacy.
    Miyajima S; Aizawa Y; Suzuki K; Satoh M; Niwano S; Ebe K; Fujita T; Ishiguro J; Hirokawa Y; Shibata A
    Jpn Heart J; 1989 Mar; 30(2):241-9. PubMed ID: 2724542
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hazards of intravenous verapamil for sustained ventricular tachycardia.
    Buxton AE; Marchlinski FE; Doherty JU; Flores B; Josephson ME
    Am J Cardiol; 1987 May; 59(12):1107-10. PubMed ID: 3578051
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Procainamide-induced slowing of ventricular tachycardia with insights from analysis of resetting response patterns.
    Stamato NJ; Frame LH; Rosenthal ME; Almendral JM; Gottlieb CD; Josephson ME
    Am J Cardiol; 1989 Jun; 63(20):1455-61. PubMed ID: 2729132
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Electrophysiological evaluation of the treatment of patients with recurrent ventricular tachycardia].
    Mendoza I; Moleiro F; Castellanos A; Casal H; Arends E; Medina V
    Arch Inst Cardiol Mex; 1982; 52(4):301-11. PubMed ID: 7138133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coronary venous retroinfusion of procainamide: a new approach for the management of spontaneous and inducible sustained ventricular tachycardia during myocardial infarction.
    Karagueuzian HS; Ohta M; Drury JK; Fishbein MC; Meerbaum S; Corday E; Mandel WJ; Peter T
    J Am Coll Cardiol; 1986 Mar; 7(3):551-63. PubMed ID: 3950235
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Idiopathic recurrent ventricular tachycardia: role of verapamil in its treatment].
    González R; Fajuri A; Arriagada C; Marchesse M; Serrat H
    Rev Med Chil; 1989 Apr; 117(4):440-4. PubMed ID: 2519400
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparative studies on the anti-arrhythmic and anti-fibrillatory effectiveness of verapamil and nifedipine following acute coronary artery occlusion and reperfusion].
    Gülker H; Thale J; Brisse B; Bender F
    Z Kardiol; 1984 Aug; 73(8):515-24. PubMed ID: 6495811
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modification of ventricular tachycardia by procainamide in patients with coronary artery disease.
    Engel TR; Meister SG; Luck JC
    Am J Cardiol; 1980 Dec; 46(6):1033-8. PubMed ID: 7446417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Initiation of ventricular tachycardia by supraventricular beats.
    Belhassen B; Shapira I; Kauli N; Keren A; Laniado S
    Cardiology; 1982; 69(4):203-13. PubMed ID: 7172169
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Verapamil-sensitive idiopathic left ventricular tachycardia in a 6-month-old: unique considerations in diagnosis and management in an infant.
    Hiremath G; Li W; Foltz R; Roy-Burman A; Cocalis M; Tanel RE
    Pediatr Emerg Care; 2015 Jan; 31(1):50-3. PubMed ID: 25526021
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of verapamil in chronic, recurrent ventricular tachycardia.
    Mason JW; Swerdlow CD; Mitchell LB
    Am J Cardiol; 1983 Jun; 51(10):1614-7. PubMed ID: 6858866
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term lorcainide therapy in patients with ventricular tachycardia.
    Somberg J; Butler B; Flowers D; Keefe D; Torres V; Miura D
    Am Heart J; 1985 Jan; 109(1):33-40. PubMed ID: 3966330
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapy for late post infarction ventricular tachycardia.
    Somberg JC; Butler B; Torres V; Tepper D; Keren G; Siegel L; Jentzer J; Miura DS
    Angiology; 1985 Mar; 36(3):181-90. PubMed ID: 3896040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [QT time and the ventricular refractory period in programmed electrical stimulation of the heart in patients with ventricular and supraventricular tachycardias--effect of sotalol].
    Wehr M
    Z Kardiol; 1986 Dec; 75(12):744-50. PubMed ID: 3825224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proarrhythmic effects of procainamide and tocainide in a canine infarction model.
    Steinberg JS; Sahar DI; Rosenbaum M; Cook JR; Bigger JT
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):52-9. PubMed ID: 1375688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dissociation of termination and prevention of inducibility of sustained ventricular tachycardia with infusion of procainamide: evidence for distinct mechanisms.
    Callans DJ; Marchlinski FE
    J Am Coll Cardiol; 1992 Jan; 19(1):111-7. PubMed ID: 1729321
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anterior left ventricular aneurysm: factors associated with the development of sustained ventricular tachycardia.
    Miller JM; Vassallo JA; Kussmaul WG; Cassidy DM; Hargrove WC; Josephson ME
    J Am Coll Cardiol; 1988 Aug; 12(2):375-82. PubMed ID: 3392330
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of intravenous and oral flecainide on ventricular tachycardia.
    Ward DE; Cheesman M; Dancy M
    Int J Cardiol; 1986 Mar; 10(3):251-62. PubMed ID: 3957470
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of procainamide on ventricular tachycardia: relation to prolongation of refractoriness and slowing of conduction.
    Furukawa T; Rozanski JJ; Moroe K; Gosselin AJ; Lister JW
    Am Heart J; 1989 Oct; 118(4):702-8. PubMed ID: 2801477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.